Effects of acetazolamide on cerebral blood flow and brain tissue oxygenation. Issue 737 (March 1987)

• Record Type: Journal Article
• Authors: Lassen, N. A.; Friberg, L.; Kastrup, J.; Rizzi, D.; Jensen, J. J.
• Is Part Of: Postgraduate medical journal. Volume 63:Issue 737(1987)
• Page Start: 185
• Page End: 187
• Publication Date: 1987-03
• Subjects: Medicine -- Periodicals; 610
• DOI: 10.1136/pgmj.63.737.185
• Languages: English
• ISSNs: 0032-5473

Abstract

Abstract : Oral administration of 1 g of acetazolamide to 8 normal subjects studied at sea level and in normoxia caused an acute increase in cerebral blood flow (CBF). During the subsequent prolonged oral treatment with 1 g of acetazolamide daily, CBF returned to normal within 2 days. The alveolar CO2 tension decreased gradually to 70% of the control value, indicating hyperventilation. At sea level hyperventilation will not increase brain oxygenation significantly in normal man, as the arterial oxygen content only increases minimally, while CBF is unchanged. At high altitude the beneficial effects of acetazolamide on the symptoms of acute mountain sickness may well be due to an improved oxygen supply to the brain, as hyperventilation will, at the low ambient PO2, cause a significant increase of the arterial oxygen content, while CBF presumably is unaffected by the drug. During hypoxia at high altitude the overall effect of prolonged acetazolamide treatment may thus be equivalent to a descent by several hundred metres.